NCT05343221 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Panchal AR, Berg KM, Hirsch KG, Kudenchuk PJ, Del Rios M, Cabañas JG, Link MS, Kurz MC, Chan PS, Morley PT, Hazinski MF, Donnino MW
2019 American Heart Association Focused Update on Advanced Cardiovascular Life Support: Use of Advanced Airways, Vasopress
Su XH, Deng Z, He BW, Liu YQ
Haptic-based virtual reality simulator for lateral ventricle puncture operation. Int J Med Robot. 2020 Dec;16(6):1-10. doi: 10.1002/rcs.2176. Epub 2020 Oct 12.
Unver V, Basak T, Watts P, Gaioso V, Moss J, Tastan S, Iyigun E, Tosun N
The reliability and validity of three questionnaires: The Student Satisfaction and Self-Confidence in Learning Scale, Simulation Design Scale, and Educational Practices Questionnair
Winship C, Williams B, Boyle MJ
Cardiopulmonary resuscitation before defibrillation in the out-of-hospital setting: a literature review. Emerg Med J. 2012 Oct;29(10):826-9. doi: 10.1136/emermed-2011-200080. Epub 2011 Nov 22. Review.

The Effect of Haptic and Highly Fidelity Simulator Use on Knowledge, Skills, Satisfaction and Self-Confidence Levels in Cardiopulmonary Resuscitation Training: A Randomized Controlled Study

Details for clinical trial NCT05343221

Clinical trial NCT05343221 - References